Publications by the researcher in collaboration with Vivencio Vicente Barrios Alonso (17)

2025

  1. Artificial intelligence: a promising tool for the clinical cardiologist

    Expert Review of Cardiovascular Therapy

  2. The gut microbiota and its role in the development of cardiovascular disease

    Expert review of cardiovascular therapy, Vol. 23, Núm. 1-2, pp. 23-34

2024

  1. Clinical profile and outcomes in very elderly patients with atrial fibrillation anticoagulated with rivaroxaban: data from the EMIR study

    Journal of Geriatric Cardiology, Vol. 21, Núm. 7, pp. 723-732

2023

  1. Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban

    Journal of comparative effectiveness research, Vol. 12, Núm. 3, pp. e220049

2022

  1. Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice

    Revista Española de Cardiología (English Edition), Vol. 75, Núm. 5, pp. 364-369

  2. Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study

    Cardiology Journal, Vol. 29, Núm. 6, pp. 936-947

  3. Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study

    Cardiology Journal, Vol. 29, Núm. 4, pp. 601-609

  4. Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry

    European heart journal. Cardiovascular pharmacotherapy, Vol. 9, Núm. 1, pp. 38-46

  5. Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries

    Journal of comparative effectiveness research, Vol. 11, Núm. 16, pp. 1173-1184

  6. Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study

    European Journal of Clinical Investigation

2021

  1. Comments on the 2020 ESC/EACTS guidelines for the management of atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 378-383

  2. Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: Impact of inappropriate doses (the EMIR study)

    Journal of Comparative Effectiveness Research, Vol. 10, Núm. 7, pp. 583-593

2020

  1. Management of patients with heart failure treated in cardiology consultations: IC-BERG Study

    Revista Clinica Espanola, Vol. 220, Núm. 6, pp. 339-349

2019

  1. Comentarios a la guía ESC/ESH 2018 sobre el diagnóstico y tratamiento de la hipertensión arterial

    Revista Espanola de Cardiologia, Vol. 72, Núm. 2, pp. 104-108

  2. Recommendations to improve the management and the prognosis of patients with heart failure

    Future Cardiology, Vol. 16, Núm. 1, pp. 1-4

2018

  1. Comments on the 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases

    Revista espanola de cardiologia (English ed.), Vol. 71, Núm. 2, pp. 74-78

2011

  1. Comments on the ESC/EAS guidelines for the management of dyslipidaemias 2011. A report of the task force of the clinical practice guidelines committee of the Spanish society of cardiology

    Revista Espanola de Cardiologia, Vol. 64, Núm. 12, pp. 1090-1095